Skip to content
ClinicalEvidence

Elicit alternative for clinical trial evidence and pharma research teams

ClinicalEvidence is an Elicit alternative for pharma, CRO and medical affairs teams that need cited answers across ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP and PubMed. It combines trial tables, status alerts and pooled team seats, with every sentence cited to an NCT number or PMID. Elicit is the better pick for a full systematic literature review of papers; ClinicalEvidence fits teams whose purchasing decision centers on trial registry evidence.

Every sentence cited to an NCT number or PMID. Professional use, no patient data needed.

Clinician reading a printed trial protocol

When trial research needs broader registry coverage

Elicit supports paper research and clinical trial screening. Its Clinical Trials announcement names ClinicalTrials.gov as the trial source and does not list EU CTR or WHO ICTRP. That distinction matters when your question covers programs outside the US, where registry records can inform the landscape before a journal paper appears.

  • Clinical development teams evaluating an international program need to consider records in EU CTR and WHO ICTRP alongside ClinicalTrials.gov.
  • CRO feasibility teams need status, enrollment and locations to examine recruitment activity. Paper summaries alone do not answer those operational questions.
  • Medical affairs teams need to distinguish a registered endpoint from posted results before drafting an evidence statement.
  • Research leads need to budget for colleagues who share evidence work. Elicit Pro and Scale use per-user pricing; ClinicalEvidence team plans pool answers across included seats.
  • Teams monitoring a landscape need alerts on new trials and status changes so they can revisit the underlying records.

ClinicalEvidence is not affiliated with Elicit. Choose according to the sources, deliverables and team workload your subscription needs to support.

Compare Elicit with a trial evidence workspace

Elicit's pricing page describes its paper research workflows and plan limits. Its Clinical Trials announcement describes registry screening and extraction. For features outside those published details, confirm with Elicit.

ElicitClinicalEvidence
Who it is forResearchers searching papers, screening reviews and extracting study dataClinical development, medical affairs, CRO, HEOR and academic trial teams
PricePro 49 USD per user per month billed annually; Scale 169 USD per user per month billed annually; Enterprise customClinician 49 USD monthly or 24 USD per month billed yearly; Research Team 199 USD monthly or 99 USD per month billed yearly
SourcesSearch across 138M+ papers; Clinical Trials uses ClinicalTrials.govClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP, PubMed and PubMed Central open access full text where licenses allow
Trial registriesClinicalTrials.gov, about 545 000 trials; for EU CTR or WHO ICTRP coverage, confirm with ElicitClinicalTrials.gov, EU CTR and WHO ICTRP; index refreshes daily
CitationsClinical Trials extraction includes citations; for sentence level verification, confirm with ElicitEvery sentence cited to an NCT number or PMID, with automatic citation verification
Systematic review screeningPro screens 5 000 papers; Enterprise screens 40 000Cited answers and trial tables; choose Elicit for a full systematic literature review of papers
Team seatsScale includes real time collaboration, admin panel and seat management; priced per userResearch Team includes 3 seats, Organization 10, Enterprise up to 50
AlertsFor new trial and status change alerts, confirm with ElicitAlerts on new trials and status changes
ExportsFor export formats, confirm with ElicitCSV, RIS and BibTeX on every plan; XLSX and DOCX from Research Team
Best forSystematic paper reviews and structured extraction from papersRegistry landscapes, cited trial answers and shared evidence work

Elicit wins on its very large paper corpus, mature systematic review screening and paper extraction workflows. Pro includes custom extractions from uploaded papers, API access, 20 table columns and reports from up to 135 sources. Scale adds figure extraction, 5x usage, 30 columns and reports from up to 200 sources. Basic includes unlimited paper search, summaries, chat with papers and Zotero import, with limited Research Agent and Reports usage. Enterprise includes 40 columns, SSO/SAML and no training on your data by default.

Follow a question from registry search to cited answer

Begin with a population, intervention and endpoint. Decide whether you need a trial landscape, posted results or publications that help interpret the evidence.

  1. Use clinical trial search to investigate registered studies alongside the literature. The index covers ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP, PubMed and PubMed Central open access full text where licenses allow, and refreshes daily.

  2. For European programs, review the role of the EU Clinical Trials Register in your search scope. Registry coverage belongs in the research question before you compare summaries.

  3. Read the cited answer and inspect its supporting passages. Automatic citation verification checks the references and support for each sentence. No verified source, no answer.

  4. Inspect the trial table, compare interventions and return to the records before using a conclusion in your deliverable.

If you are comparing OpenEvidence too, review that comparison against the same source and team requirements.

Claims with traceable references

Every sentence links to an NCT number or PMID. Open the source and assess whether the passage supports the claim you plan to use. Citation verification helps establish traceability; your team still evaluates study quality, relevance and whether the evidence supports the intended medical or research statement.

Registry details beside the answer

The trial table shows phase, population, interventions, endpoints, results posted, sponsor, status, enrollment, dates and locations. Review the results field before treating a planned endpoint as an observed finding. For feasibility work, inspect locations and enrollment alongside status, then check the source record before drawing an operational conclusion.

Intervention comparisons with context

Intervention comparisons help teams examine the evidence behind competing approaches. Read them alongside the populations, endpoints and trial designs in the underlying studies. Results from separate studies require appraisal before you use them to support a treatment comparison or a development decision.

Updates your colleagues can review

Alerts track new trials and status changes. Research Team adds shared workspaces, comments and roles, so colleagues can review evidence together. Export the table or references in your plan's formats when a landscape needs discussion outside the workspace. Revisit the cited records before revising a report after an alert.

Match the workspace to your research deliverable

  • Pharma clinical development teams reviewing competing programs, registered endpoints and evidence gaps before protocol discussions.
  • CRO feasibility teams examining status, enrollment and locations across relevant trials.
  • Medical affairs teams preparing referenced responses and checking whether a claim rests on registry information or published findings.
  • HEOR consultants collecting trial evidence and references for client review, while appraising study differences before interpreting outcomes.
  • Academic trial researchers scoping registered studies and related publications before defining a research question.

For a paper screening project, review systematic review software requirements and choose Elicit when the deliverable is a full systematic literature review of papers. For broader scoping, consider how an AI literature review fits alongside registry research. A team can need both workflows without expecting the same subscription to replace every research method.

Budget for the people doing trial evidence work

ClinicalEvidence carries no advertising. Monthly and yearly billing cover different team sizes and evidence workloads.

  • Clinician costs 49 USD per month or 24 USD per month billed yearly (288 USD). It includes 200 answers, 1 seat, up to 50 studies per answer, 5 alerts, CSV, RIS and BibTeX.
  • Research Team costs 199 USD per month or 99 USD per month billed yearly (1 188 USD). It includes 800 pooled answers, 3 seats, up to 200 studies per answer, 25 alerts, shared workspaces, comments, roles and CSV, XLSX, DOCX, RIS and BibTeX.
  • Organization costs 499 USD per month or 249 USD per month billed yearly (2 988 USD). It includes 2 000 pooled answers, 10 seats, up to 500 studies per answer, 100 alerts, bulk CSV, an audit log and invoicing.
  • Enterprise costs 1 490 USD per month or 745 USD per month billed yearly (8 940 USD). It includes 6 000 pooled answers, up to 50 seats, up to 1 000 studies per answer, 500 alerts and SAML SSO.

For three people, Elicit Scale costs 3 x 169 = 507 USD per month billed annually. Research Team covers 3 seats for 99 USD per month billed yearly. This compares the cost of equipping a trial workflow. The products do different jobs, so evaluate the registry work your team needs alongside Elicit's paper screening and extraction strengths. Check limits and billing on pricing.

Common questions when evaluating Elicit

Is there a better alternative to Elicit?

ClinicalEvidence is a better fit when your priority is trial registry coverage and pooled team access. It searches ClinicalTrials.gov, EU CTR and WHO ICTRP alongside PubMed, with cited answers, trial tables and alerts. Elicit is the better pick for a full systematic literature review of papers.

How much does Elicit cost?

Elicit's pricing page lists Pro at 49 USD per user per month billed annually, totaling 588 USD per year. Scale costs 169 USD per user per month billed annually, totaling 2 028 USD per year. Enterprise has custom pricing. For other billing terms, confirm with Elicit.

Does Elicit search clinical trials?

Yes. Elicit Clinical Trials searches ClinicalTrials.gov, covering about 545 000 trials, and is available to paying Elicit users. Users can screen protocol and registration information and extract custom data into tables with citations. Its announcement does not list EU CTR or WHO ICTRP; for coverage beyond ClinicalTrials.gov, confirm with Elicit.

Is Elicit good for systematic reviews?

Yes. Elicit is the better pick for a full systematic literature review of papers, with mature screening and data extraction workflows. Pro supports screening 5 000 papers, while Enterprise supports 40 000. Elicit also offers a very large paper corpus, Zotero import and API access, with figure extraction on Scale.

What is the best Elicit alternative for pharma teams?

ClinicalEvidence is a strong Elicit alternative for pharma teams whose work centers on registered trials, cited answers and shared evidence review. It covers ClinicalTrials.gov, EU CTR and WHO ICTRP alongside PubMed. Research Team includes 3 seats and 800 pooled answers. The best choice depends on your sources and deliverables.

Can I use ClinicalEvidence and Elicit together?

Yes. Use Elicit for systematic paper screening and extraction, and ClinicalEvidence for trial registry landscapes, cited answers and status alerts. This combination suits teams that need both published study appraisal and ongoing registry research. Check the underlying sources in each workflow before carrying conclusions into a medical response or research report.

Put your next trial question to work

Bring a current research question, inspect the citations and trial records, and choose the workspace that fits your team's evidence work.